Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,354 | 1,121 | 96.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $369.57 | 23 | 1.7% |
| Travel and Lodging | $274.68 | 2 | 1.2% |
| Education | $189.49 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,327 | 99 | $0 (2024) |
| UCB, Inc. | $1,264 | 77 | $0 (2024) |
| SK Life Science, Inc. | $1,065 | 42 | $0 (2024) |
| Lundbeck LLC | $1,063 | 43 | $0 (2024) |
| Eisai Inc. | $967.68 | 48 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $879.83 | 32 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $773.98 | 46 | $0 (2022) |
| Allergan, Inc. | $750.98 | 58 | $0 (2022) |
| Lilly USA, LLC | $698.76 | 34 | $0 (2024) |
| Amgen Inc. | $696.15 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,655 | 191 | Lundbeck LLC ($476.45) |
| 2023 | $3,763 | 171 | SK Life Science, Inc. ($302.68) |
| 2022 | $2,613 | 126 | Teva Pharmaceuticals USA, Inc. ($217.43) |
| 2021 | $3,069 | 178 | AbbVie Inc. ($287.39) |
| 2020 | $2,034 | 124 | Harmony Biosciences LLC ($199.44) |
| 2019 | $2,721 | 152 | Greenwich Biosciences, Inc. ($210.93) |
| 2018 | $1,751 | 100 | Medtronic USA, Inc. ($307.31) |
| 2017 | $1,583 | 106 | UCB, Inc. ($283.23) |
All Payment Transactions
1,148 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Neurology | ||||||
| 12/16/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: Immunology and Neurology | ||||||
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Neurology | ||||||
| 12/05/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $36.16 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $32.67 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.49 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $43.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.39 | General |
| 12/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Neurology | ||||||
| 12/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: NEUROLOGY | ||||||
| 11/25/2024 | PFIZER INC. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 11/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: Narcoplepsy | ||||||
| 11/20/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.36 | General |
| 11/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $0.57 | General |
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $9.55 | General |
| Category: Narcoplepsy | ||||||
| 11/14/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $3.51 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 930 | 1,061 | $246,419 | $77,684 |
| 2022 | 12 | 837 | 936 | $235,839 | $74,718 |
| 2021 | 10 | 727 | 933 | $223,478 | $83,155 |
| 2020 | 15 | 1,025 | 1,363 | $537,689 | $112,761 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 318 | $71,250 | $28,447 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 115 | 115 | $42,383 | $12,981 | 30.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 77 | 80 | $28,380 | $7,403 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 113 | $16,452 | $6,529 | 39.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 57 | 57 | $19,389 | $4,755 | 24.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 119 | 119 | $13,232 | $3,642 | 27.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 30 | 31 | $10,782 | $1,986 | 18.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $6,636 | $1,795 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,732 | $1,701 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,081 | $1,662 | 40.7% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 25 | 25 | $8,350 | $1,558 | 18.7% |
| 93660 | Evaluation of heart function using tilt table | Office | 2023 | 17 | 17 | $5,737 | $1,517 | 26.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 33 | 33 | $5,181 | $1,308 | 25.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 23 | 23 | $3,611 | $970.14 | 26.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 32 | 32 | $3,488 | $719.84 | 20.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 49 | $2,735 | $712.46 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 174 | 230 | $48,126 | $19,685 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 122 | 122 | $42,153 | $14,838 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 223 | $30,231 | $13,440 | 44.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 112 | 112 | $35,308 | $9,104 | 25.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 82 | 82 | $26,786 | $7,664 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 30 | 30 | $5,928 | $2,276 | 38.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,463 | $1,998 | 26.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $4,670 | $1,837 | 39.3% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 31 | 32 | $25,632 | $1,421 | 5.5% |
About Dr. Mahmood Eisa, MD
Dr. Mahmood Eisa, MD is a Neurology healthcare provider based in Valdosta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184606824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mahmood Eisa, MD has received a total of $22,188 in payments from pharmaceutical and medical device companies, with $4,655 received in 2024. These payments were reported across 1,148 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($21,354).
As a Medicare-enrolled provider, Eisa has provided services to 3,519 Medicare beneficiaries, totaling 4,293 services with total Medicare billing of $348,317. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Valdosta, GA
- Active Since 11/17/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1184606824
Products in Payments
- APTIOM (Drug) $1,027
- VYEPTI (Biological) $824.43
- Briviact (Drug) $801.15
- Fycompa (Drug) $787.59
- BOTOX (Biological) $762.01
- Aimovig (Biological) $591.04
- VALTOCO (Drug) $569.31
- NURTEC ODT (Drug) $528.66
- Epidiolex (Drug) $459.88
- UBRELVY (Drug) $448.88
- ULTOMIRIS (Biological) $419.87
- XCOPRI (Drug) $413.37
- NUEDEXTA (Drug) $411.88
- AUSTEDO (Drug) $362.88
- INGREZZA (Drug) $335.69
- ACTIVA (Device) $307.31
- NOURIANZ (Drug) $302.44
- QULIPTA (Drug) $301.97
- GOCOVRI (Drug) $297.78
- AUBAGIO (Drug) $293.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Valdosta
Sheri Swader, M.d, M.D
Neurology — Payments: $9,665
Dr. Steven Dawson, M.d, M.D
Neurology — Payments: $9,259
Jonathan Sule, M.d, M.D
Neurology — Payments: $2,978
Dr. Penelope Edwards-Conrad, Md, MD
Neurology — Payments: $54.35
Dr. Joseph Robison, Pt, Dpt, Msc, Ncs, PT, DPT, MSC, NCS
Neurology